HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$3.11
Day range
$2.96 - $3.12
Year range
$2.36 - $7.22
Market cap
92.03M USD
Avg Volume
99.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.99M | -18.35% |
Net income | -21.83M | 17.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 83.61M | -36.87% |
Total assets | 84.41M | -37.74% |
Total liabilities | 12.36M | 22.43% |
Total equity | 72.05M | — |
Shares outstanding | 30.17M | — |
Price to book | 1.30 | — |
Return on assets | -63.17% | — |
Return on capital | -73.02% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -21.83M | 17.07% |
Cash from operations | -13.04M | 21.01% |
Cash from investing | 10.06M | -74.86% |
Cash from financing | 221.75K | — |
Net change in cash | -2.76M | -111.73% |
Free cash flow | -5.47M | 23.52% |
About
Founded
2012
Headquarters
Website
Employees
20